PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO)(Euronext Paris: BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, announces today that its 2009 Annual Financial Report has been sent to the French Market Authorities and may be consulted at the http://www.bioalliancepharma.com website.